Form 4: BDX Executive Sells Shares Under 10b5-1 Plan

Becton Dickinson & Co. EVP Michael Feld sold 57 shares of common stock for $186.01 per share under a pre-arranged 10b5-1 plan.

Summary

• Michael Feld, EVP & President, Life Sciences at Becton Dickinson & Co. (BDX), reported a transaction involving the company's common stock.
• The transaction occurred on October 27, 2025, and involved the disposition (sale) of 57 shares of common stock.
• Each share was sold at a price of $186.01.
• Following this transaction, Michael Feld beneficially owns 8,245 shares of Becton Dickinson & Co. common stock directly.
• This transaction was executed pursuant to a Rule 10b5-1 plan, which was adopted by Michael Feld on February 7, 2025.

Sentiment

Score: 5

Explanation: The sentiment is neutral. A small insider sale under a pre-arranged 10b5-1 plan is generally considered a routine event and does not typically signal strong positive or negative sentiment regarding the company's future prospects.

Positives

• The transaction was conducted under a Rule 10b5-1 plan, indicating it was pre-scheduled and not based on immediate, non-public information, which enhances transparency and reduces concerns about opportunistic insider trading.

Negatives

• An insider sale, even if pre-arranged, reduces the overall direct beneficial ownership of an executive in the company.

Risks

• NA

Future Outlook

NA

Industry Context

This insider transaction is specific to Becton Dickinson & Co. and does not directly reflect broader industry trends or competitive dynamics. It is a routine disclosure of an executive's personal stock activity.

Comparison to Industry Standards

• NA

Stakeholder Impact

• Shareholders: The impact on shareholders is minimal due to the small number of shares sold relative to the company's total outstanding shares and the pre-arranged nature of the transaction.

Key Dates

Recommendation

This Form 4 filing details a routine, pre-scheduled insider stock sale under a 10b5-1 plan. The transaction size is small relative to the company's market capitalization and the executive's total holdings. Such a transaction typically does not provide sufficient new information to warrant a change in investment recommendation. Investors should consider broader company fundamentals and market conditions rather than this isolated insider transaction.

Keywords

Becton Dickinson, BDX, Michael Feld, Insider Transaction, Form 4, Stock Sale, 10b5-1 Plan, Executive Compensation